Stockscreener 앱 받기
1.35
9.76%
0.12
시간 외 거래:
1.34
-0.01
-0.74%
전일 마감가:
$1.23
열려 있는:
$1.3
하루 거래량:
2.12M
Relative Volume:
0.86
시가총액:
$22.97M
수익:
-
순이익/손실:
$-39.14M
주가수익비율:
-0.2261
EPS:
-5.97
순현금흐름:
$-28.20M
1주 성능:
+1.50%
1개월 성능:
-7.53%
6개월 성능:
-25.00%
1년 성능:
-90.58%
1일 변동 폭
$1.29
$1.43
1주일 범위
$1.18
$1.45
52주 변동 폭
$0.65
$17.00
Citius Pharmaceuticals Inc Stock (CTXR) Company Profile
명칭
Citius Pharmaceuticals Inc
전화
(908) 967-6676
주소
11 COMMERCE DRIVE, CRANFORD, NJ
CTXR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTXR
Citius Pharmaceuticals Inc
|
1.35 | 23.48M | 0 | -39.14M | -28.20M | -5.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-30 | 업그레이드 | D. Boral Capital | Hold → Buy |
| 2021-11-30 | 개시 | Maxim Group | Buy |
Citius Pharmaceuticals Inc 주식(CTXR)의 최신 뉴스
Citius Oncology Announces Closing of $9.0 Million Public Offering - ADVFN Brasil
Citius Pharma Reports Q2 2025 Financial Results - TipRanks
Using flow based indicators on Citius Pharmaceuticals Inc.July 2025 Technicals & Fast Moving Stock Watchlists - Newser
Predicting Citius Pharmaceuticals Inc. trend using moving averagesQuarterly Performance Summary & Consistent Return Investment Signals - Newser
Chart overlay techniques for tracking Citius Pharmaceuticals Inc.Market Activity Summary & Daily Momentum Trading Reports - Newser
Tick level data insight on Citius Pharmaceuticals Inc. volatilityGap Up & Community Consensus Trade Alerts - Newser
What technical models suggest about Citius Pharmaceuticals Inc.’s comebackEarnings Miss & AI Driven Stock Price Forecasts - Newser
What the charts say about Citius Pharmaceuticals Inc. todayJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - Newser
Will Citius Pharmaceuticals Inc. stock go up in YEARWeekly Investment Recap & Daily Chart Pattern Signals - mustnews.co.kr
Intraday pattern recognizer results for Citius Pharmaceuticals Inc.Quarterly Growth Report & Fast Entry Momentum Trade Alerts - Newser
AI Indicators Detect Buy Opportunity in Citius Pharmaceuticals Inc.July 2025 Trade Ideas & Consistent Profit Trading Strategies - beatles.ru
Price momentum metrics for Citius Pharmaceuticals Inc. explainedJuly 2025 Rallies & Verified Momentum Stock Ideas - Newser
Building trade automation scripts for Citius Pharmaceuticals Inc.Quarterly Profit Summary & Smart Money Movement Alerts - Newser
Why Citius Pharmaceuticals Inc. is moving todayIPO Watch & Low Drawdown Investment Strategies - Newser
Using R and stats models for Citius Pharmaceuticals Inc. forecastingSwing Trade & Weekly High Conviction Ideas - Newser
Ichimoku Cloud Indicates Uncertainty Around Citius Pharmaceuticals Inc.Trade Risk Report & Smart Allocation Stock Reports - 선데이타임즈
What is Citius Pharmaceuticals Inc. s debt to equity ratioEarnings Performance Report & Short-Term Trading Alerts - 선데이타임즈
Tools to assess Citius Pharmaceuticals Inc.’s risk profileMarket Trend Summary & Free Weekly Watchlist of Top Performers - Newser
Published on: 2025-08-15 17:50:31 - Newser
Citius Pharmaceuticals Q3 Earnings: Net Loss Narrows, Revenue Falls Short of Expectations. - AInvest
Citius Pharmaceuticals regains Nasdaq compliance with minimum bid price requirement. - AInvest
Citius Pharmaceuticals Inc. Volume Confirms Breakout — Analysts BullishFed Meeting & Consistent Profit Trade Alerts - beatles.ru
Citius Pharmaceuticals Inc. Uptrend in Early Stages Indicators Say YesPortfolio Value Report & Consistent Income Trade Ideas - thegnnews.com
Citius Pharmaceuticals (NASDAQ:CTXR) Receives “Buy” Rating from D. Boral Capital - Defense World
Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update - The Malaysian Reserve
Citius Posts Wider Loss in Fiscal Q3 - The Globe and Mail
Citius: D. Boral Capital raises PT to $6, maintains Buy rating. - AInvest
Citius Pharmaceuticals shares fall 3.85% intraday after reporting fiscal third quarter results and raising $12.5 million in financings. - AInvest
Press Release: Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update - 富途牛牛
Citius Pharmaceuticals (NASDAQ:CTXR) Trading Up 4% – Time to Buy? - Defense World
Citius Oncology Beats Q3 EPS Estimates with $0 Revenue - AInvest
Citius Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Citius Pharmaceuticals reports Q3 EPS (8c) vs.(7c) last year - TipRanks
LYMPHIR Launch Readiness vs. Cash Shortfall: Citius Oncology Raises $9M - Stock Titan
Citius Oncology Secures $21.5M Funding to Launch New Lymphoma Treatment LYMPHIR - Stock Titan
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update - Ariva
Why Citius Pharmaceuticals Inc. stock attracts strong analyst attention2x Return in 30 Days Picks - 한국정경신문
Citius Oncology Announces Pricing of $9.0 Million Public Offering - ADVFN Brasil
Is Citius Pharmaceuticals Inc. stock a growth or value playTechnical Screener for High Growth Stocks - Newser
Sector ETF performance correlation with Citius Pharmaceuticals Inc.Risk Shielded Trade Watch with Analysis - Newser
Citius Oncology IncAnticipates Commercial Launch of Lymphir in 2025 - 富途牛牛
Citius Pharmaceuticals (CTXR) Expected to Announce Quarterly Earnings on Monday - Defense World
Citius CTXR 2025Q3 Earnings Preview Upside Ahead on Potential New Product Launch - AInvest
Published on: 2025-08-04 16:39:39 - beatles.ru
Published on: 2025-08-04 09:23:45 - beatles.ru
What is the dividend policy of Citius Pharmaceuticals Inc. stockMaximize your gains with expert trading tips - Jammu Links News
When is Citius Pharmaceuticals Inc. stock expected to show significant growthSpectacular growth rates - Jammu Links News
What are Citius Pharmaceuticals Inc. company’s key revenue driversUnstoppable trading performance - Jammu Links News
What institutional investors are buying Citius Pharmaceuticals Inc. stockAchieve breakthrough investment performance - Jammu Links News
Is Citius Pharmaceuticals Inc. a good long term investmentExceptional ROI - Jammu Links News
Why is Citius Pharmaceuticals Inc. stock attracting strong analyst attentionExceptional trading performance - Jammu Links News
Citius Pharmaceuticals Inc (CTXR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.94%
1.72%
자본화:
|
볼륨(24시간):